Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Juan Carlos, Quer"'
Autor:
Maria Buti, Dúnia Pérez del Campo, Gema Fernández, Maria Antònia Llopis, Laura Calatayud, Adriana Palom, Ariadna Rando-Segura, Alicia Sellés-Sánchez, Saray Mormeneo Bayo, Maria Mar Olga Perez Moreno, David Tabernero, Josefina Ayats, Juan Carlos Quer
Publikováno v:
BMJ Open, Vol 14, Iss 11 (2024)
Introduction Hepatitis B virus (HBV) affects 296 million people globally, causing 780 000 annual deaths. It has been estimated that 12–43 million individuals are co-infected with hepatitis D virus (HDV). In Spain, the prevalence of HBsAg in adults
Externí odkaz:
https://doaj.org/article/56862b4020c14f23a1c29e7cdcbee89d
Autor:
Juan Carlos, Quer, Moisés, Diago, Javier, Crespo, Javier, García-Samaniego, Rosa, Morillas, Raúl, Andrade, Miguel, Ángel Simón
Publikováno v:
Gastroenterologia y hepatologia. 37
Chronic hepatitis C virus infection is usually asymptomatic. The severity of the hepatic lesion in these patients at diagnosis varies and, from the histopathologic point of view, most have mild disease. A series of factors have been described that co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d04470cf15b0a22d3ad417efc9055b6
https://pubmed.ncbi.nlm.nih.gov/25907433
https://pubmed.ncbi.nlm.nih.gov/25907433
Autor:
Miquel, Bruguera, Rafael, Esteban, Xavier, Forns, Ramón, Planas, Juan Carlos, Quer, Ricard, Solà, Mercè, Vergara
Publikováno v:
Gastroenterologia y hepatologia. 35(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6cc69764fd1b1edd88ee257f0af76ab4
https://pubmed.ncbi.nlm.nih.gov/22560187
https://pubmed.ncbi.nlm.nih.gov/22560187
Autor:
Ramon, Planas, Juan Carlos, Quer, Jaime, Enríquez, Josep Maria, Barrera, Blai, Dalmau, Teresa, Casanovas, Josep Maria, Viver, Miquel, Torres, Jaume, Boadas, Ricart, Solà, Rosa, Durández, Cristóbal, Richart, Miquel, Bruguera
Publikováno v:
Medicina clinica. 118(17)
Although standard dose interferon (IFN) is successful in only 5% of patients with compensated hepatitis C virus (HCV)-related cirrhosis, it has been suggested that this therapy might decrease the risk of complications or the incidence of hepatocellul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e703433cdf4e8604c369419b90aad87
https://pubmed.ncbi.nlm.nih.gov/12028899
https://pubmed.ncbi.nlm.nih.gov/12028899